Meet the organisers
Dr Mads E. Israelsen
Mads Israelsen, MD, PhD, post doc at Department of Gastroenterology and Hepatology, Odense University Hospital and University of Southern Denmark.
Click to read more
My research is focused on alcohol-related liver disease, microbiome and cirrhosis. I am involved in the H2020 projects GALAXY, MicrobPredict, and Human Microbiome Action.
Prof. Aleksander Krag
Aleksander Krag, MD, PhD, MBA, Professor and Head of Hepatology, Director of Odense Liver Research Centre at Odense University Hospital. Chair of Health Sciences at the Danish Institute of Advanced Studies (DIAS) at University of Southern Denmark, Associate editor at Danish Medical Journal and Editor in Chief at Medicin.dk.
Click to read more
My passion is research with main focus on liver fibrosis, complications to cirrhosis, alcoholic liver disease and microbiome. I’m involved in and hold leader positions in a number of large research collaborations in liver diseases, including being director of FLASH: Fibrosis Fatty Liver and Steatohepatitis Research Centre Odense, Coordinator in the H2020 project GALAXY: Gut and Liver Axis in Alcoholic Liver Fibrosis and partner in the H2020 projects MicrobPredict, LiverScreen and The International Human Microbiome Action and PI in the Center for Functional Genomics and Tissue Plasticity. I’m involved in several international organisational activities including being member of the Scientific Committee of the Baveno group and serve as UEG representative in the European Medicines Agency. My research output and metrics are available at PubMed, Scopus, ORCID, Publons and Google.
Prof. Maja Thiele
Professor of Hepatology at Department of Gastroenterology and Hepatology, Odense University Hospital and University of Southern Denmark.
Click to read more
I work to reduce morbidity and mortality from alcohol-related liver disease, for the benefit of an otherwise stigmatized patient group. My research centers on the development and validation of diagnostic and prognostic biomarkers, with a particular focus on early disease detection and cost-effective referral pathways. Elastography expert contributor to EASL Clinical Practice Guidance, the BAVENO VII consensus statement, and AASLD clinical guidance. Partner in the European research consortia GALAXY, LiverScreen, MicrobPredict and SALVE.